A new Harris Interactive poll shows a majority of American parents believe they, rather than the government, should have the final say in which vaccines their children receive.
A new Harris Interactive poll shows a majority of American parents believe they, rather than the government, should have the final say in which vaccines their children receive.
The poll, commissioned by the Center for Personal Rights, queried a representative sample of American parents about vaccination. The survey was conducted online in May within the United States by Harris Interactive on behalf of the Center for Personal Rights, Inc., among 1,144 parents of children age 17 years or younger.
Poll results indicate a majority of American parents, 52%, believe that "parents should have the right to decide which vaccines their children receive without government mandates."
Such results may stem from recent media reports, which have since been discredited, that vaccines do more harm than good, may cause autism, or are no longer necessary for certain diseases.
“In one warning after another, vaccine opponents often exaggerate or even make up immunization risks, with no scientific evidence to support their claims,” according to a statement on the American Academy of Pediatrics website. “They may imply that vaccines aren’t effective. At the same time, they downplay or don’t discuss the serious diseases that vaccines can eliminate or reduce in frequency. No wonder some parents are left feeling anxious and, in some cases, keep their youngster unvaccinated at the risk of their child’s health.”
But those assurances may be falling on deaf ears. Other results from the Center for Personal Rights, Inc. research include:
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen